2022 Q2 Form 10-Q Financial Statement

#000114036122018849 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q1
Revenue $4.692M $5.195M
YoY Change -9.68% 6.59%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $149.0K $176.0K
YoY Change -15.34% 22.22%
% of Gross Profit
Depreciation & Amortization $202.0K $191.0K $170.0K
YoY Change 18.82% 12.35% 0.0%
% of Gross Profit
Operating Expenses $149.0K $176.0K
YoY Change -15.34% 22.22%
Operating Profit
YoY Change
Interest Expense $424.0K $753.0K
YoY Change -43.69% -43.43%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.273M $1.546M $1.813M
YoY Change -21.9% -14.73% 46.09%
Income Tax $205.0K $269.0K $395.0K
% Of Pretax Income 16.1% 17.4% 21.79%
Net Earnings $1.068M $1.277M $1.418M
YoY Change -17.85% -9.94% 45.14%
Net Earnings / Revenue 27.22% 27.3%
Basic Earnings Per Share $0.39 $0.44
Diluted Earnings Per Share $310.4K $0.37 $0.41
COMMON SHARES
Basic Shares Outstanding 3.391M 3.274M 3.219M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $64.08M $79.07M $101.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $16.25M $17.14M $14.81M
YoY Change 8.94% 15.69% 12.81%
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.143M $860.0K $1.000M
YoY Change 42.88% -14.0% 25.0%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $590.5M $574.6M $563.3M
YoY Change 4.37% 2.01% 22.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $2.606M $2.247M $2.900M
YoY Change -3.48% -22.52% 93.33%
Deferred Revenue
YoY Change
Short-Term Debt $2.704M $2.007M $2.000M
YoY Change -3.43% 0.35% -9.09%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.606M $2.247M $2.900M
YoY Change -3.48% -22.52% 93.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.606M $2.247M $2.900M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $538.1M $522.0M $511.1M
YoY Change 4.9% 2.12% 24.41%
SHAREHOLDERS EQUITY
Retained Earnings $14.51M $15.51M
YoY Change -6.23% 14.55%
Common Stock $34.00K $34.00K
YoY Change 0.0% 47.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.35M $52.63M $52.14M
YoY Change
Total Liabilities & Shareholders Equity $590.5M $574.6M $563.3M
YoY Change 4.37% 2.01% 22.32%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $1.068M $1.277M $1.418M
YoY Change -17.85% -9.94% 45.14%
Depreciation, Depletion And Amortization $202.0K $191.0K $170.0K
YoY Change 18.82% 12.35% 0.0%
Cash From Operating Activities $1.015M $9.084M $8.350M
YoY Change -89.45% 8.79% 66.0%
INVESTING ACTIVITIES
Capital Expenditures -$157.0K -$507.0K -$130.0K
YoY Change -43.93% 290.0% 160.0%
Acquisitions
YoY Change
Other Investing Activities -$31.04M -$6.586M -$13.22M
YoY Change 337.23% -50.18% -171.73%
Cash From Investing Activities -$31.20M -$7.093M -$13.36M
YoY Change 323.34% -46.91% -172.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.20M 2.682M 26.19M
YoY Change 1187.71% -89.76% 693.64%
NET CHANGE
Cash From Operating Activities 1.015M 9.084M 8.350M
Cash From Investing Activities -31.20M -7.093M -13.36M
Cash From Financing Activities 15.20M 2.682M 26.19M
Net Change In Cash -14.99M 4.673M 21.18M
YoY Change -537.03% -77.94% -20.7%
FREE CASH FLOW
Cash From Operating Activities $1.015M $9.084M $8.350M
Capital Expenditures -$157.0K -$507.0K -$130.0K
Free Cash Flow $1.172M $9.591M $8.480M
YoY Change -88.16% 13.1% 66.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001500375
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35019
dei Entity Registrant Name
EntityRegistrantName
HOME FEDERAL BANCORP, INC. OF LOUISIANA
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
LA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
02-0815311
dei Entity Address Address Line1
EntityAddressAddressLine1
624 Market Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Shreveport
dei Entity Address State Or Province
EntityAddressStateOrProvince
LA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
71101
dei City Area Code
CityAreaCode
318
dei Local Phone Number
LocalPhoneNumber
222-1145
dei Security12b Title
Security12bTitle
Common Stock (par value $0.01 per share)
dei Trading Symbol
TradingSymbol
HFBL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3390839
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-48000
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-48000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2021Q1 hfbl Stock Issued During Period Value Stock Splits
StockIssuedDuringPeriodValueStockSplits
0
hfbl Stock Issued During Period Value Stock Splits
StockIssuedDuringPeriodValueStockSplits
0
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-48000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0
us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
814000
us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
0
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
367232000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4174000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
377000
CY2021Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
341260000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4174000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4122000
CY2022Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
259000
CY2021Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
744000
CY2022Q1 us-gaap Notes Receivable Net
NotesReceivableNet
362799000
CY2021Q2 us-gaap Notes Receivable Net
NotesReceivableNet
336394000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4122000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
61000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4081000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
61000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1750000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
31000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1646000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
22000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
202000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4174000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4387000
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
367232000
CY2021Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
341260000
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
367232000
CY2022Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2021Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
341260000
CY2021Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
33000
CY2022Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
0
CY2021Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
0
us-gaap Loans And Leases Receivable Impaired Interest Income Recognized Change In Present Value Attributable To Passage Of Time
LoansAndLeasesReceivableImpairedInterestIncomeRecognizedChangeInPresentValueAttributableToPassageOfTime
0
CY2021 us-gaap Loans And Leases Receivable Impaired Interest Income Recognized Change In Present Value Attributable To Passage Of Time
LoansAndLeasesReceivableImpairedInterestIncomeRecognizedChangeInPresentValueAttributableToPassageOfTime
0
us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
43000
CY2021 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
63000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4122000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
31000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
22000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
3797000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
568000
hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceDuringPeriod
9.94
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
367232000
CY2022Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7403000
CY2022Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
359829000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4081000
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1961000
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
202000
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1800000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4122000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
3554000
CY2021Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
341260000
CY2021Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
6008000
CY2021Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
335252000
CY2022Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
7403000
CY2022Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
163000
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
7240000
CY2022Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7403000
CY2022Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
377000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
7394000
CY2021Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
6008000
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
2088000
CY2021Q2 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
3920000
CY2021Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
6008000
CY2021Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
568000
CY2021 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
6750000
hfbl Mortgage Loans In Process Of Foreclosure Number
MortgageLoansInProcessOfForeclosureNumber
1
CY2022Q1 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2022Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
148196000
CY2021Q2 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
131014000
CY2022Q1 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
55177000
CY2021Q2 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
49262000
CY2022Q1 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
97473000
CY2021Q2 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
88181000
CY2022Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
136586000
CY2021Q2 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
129130000
CY2022Q1 hfbl Transaction Accounts Amount
TransactionAccountsAmount
437432000
CY2021Q2 hfbl Transaction Accounts Amount
TransactionAccountsAmount
397587000
CY2022Q1 us-gaap Time Deposits
TimeDeposits
79438000
CY2021Q2 us-gaap Time Deposits
TimeDeposits
109009000
CY2022Q1 us-gaap Deposits
Deposits
516870000
CY2021Q2 us-gaap Deposits
Deposits
506596000
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2021Q1 hfbl Stock Dividend Rate Percentage
StockDividendRatePercentage
1
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2021-03-31
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2021-03-22
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 hfbl Common Stock Shares Outstanding Prior To Stock Split
CommonStockSharesOutstandingPriorToStockSplit
1700000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3400000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1277000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1418000
us-gaap Net Income Loss
NetIncomeLoss
3805000
us-gaap Net Income Loss
NetIncomeLoss
4068000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3274000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3219000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3238000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
191000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
235000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
227000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
153000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3465000
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3454000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3462000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3391000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2022Q1 hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberDuringPeriod
438745
CY2021Q1 hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberDuringPeriod
691445
CY2022Q1 hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceDuringPeriod
11.61
CY2021Q1 hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceDuringPeriod
9.94
hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberDuringPeriod
558175
hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberDuringPeriod
614261
hfbl Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceDuringPeriod
11.61
CY2021Q1 us-gaap Weighted Average Number Of Shares Treasury Stock
WeightedAverageNumberOfSharesTreasuryStock
2746000
us-gaap Weighted Average Number Of Shares Treasury Stock
WeightedAverageNumberOfSharesTreasuryStock
2747000
us-gaap Weighted Average Number Of Shares Treasury Stock
WeightedAverageNumberOfSharesTreasuryStock
2721000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3274000
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6124000
CY2021Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6124000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6124000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6124000
CY2022Q1 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
139000
CY2021Q1 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
159000
us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
142000
us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
165000
CY2022Q1 us-gaap Weighted Average Number Of Shares Treasury Stock
WeightedAverageNumberOfSharesTreasuryStock
2711000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3219000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3238000

Files In Submission

Name View Source Status
0001140361-22-018849-index-headers.html Edgar Link pending
0001140361-22-018849-index.html Edgar Link pending
0001140361-22-018849.txt Edgar Link pending
0001140361-22-018849-xbrl.zip Edgar Link pending
brhc10037395_10q.htm Edgar Link pending
brhc10037395_10q_htm.xml Edgar Link completed
brhc10037395_ex31-1.htm Edgar Link pending
brhc10037395_ex31-2.htm Edgar Link pending
brhc10037395_ex32-0.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hfbl-20220331.xsd Edgar Link pending
hfbl-20220331_cal.xml Edgar Link unprocessable
hfbl-20220331_def.xml Edgar Link unprocessable
hfbl-20220331_lab.xml Edgar Link unprocessable
hfbl-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending